Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 mg | Check Cart for Availability | $216.00 | |
| 500 mg | Please contact Customer Service for Availability | $622.00 | |
| 1 g | Please contact Customer Service for Availability | $1,040.00 |
About This Item
UNSPSC Code:
12352204
NACRES:
NA.54
$216.00
Check Cart for Availability
form
powder
mol wt
Mr 239.5
packaging
pkg of 1 g (11429876001), pkg of 100 mg (11429868001), pkg of 500 mg (11585916001)
manufacturer/tradename
Roche
technique(s)
blocking: suitable, protein purification: suitable
mp
175-185 °C
solubility
aqueous buffer: 100 mg/mL
storage temp.
2-8°C
General description
Pefabloc SC is a specific, potent, and irreversible inhibitor of serine proteases. The inhibitory activity is comparable to PMSF or DFP, but Pefabloc SC is non-toxic.
Application
- Pefabloc SC is used to inhibit the detrimental effects of proteases during preparative protein purification.[1][2]
- Due to its low toxicity toward eukaryotic cells, it may be applied in the production of recombinant proteins, during fermentation of transformed cells, where proteolytic digestion may decrease the yield of the desired product.[3]
- Pefabloc SC is used to completely inactivate proteinase K during the preparation of chromosomal DNA in agarose plugs. For this purpose, the cells are embedded in agarose and digested with proteinase K to degrade all proteins. Before a specific restriction endonuclease is added, the proteinase K is inactivated by incubating the agarose plugs in 1 to 5 mM Pefabloc SC in 10 mM Tris-HCl, 1 mM EDTA , pH 7 for 2 hours at +37 °C or overnight.
- In contrast to PMSF, Pefabloc SC is an excellent blocker of thrombin activity in serum or plasma. In these biological fluids, PMSF interacts in a reversible manner with albumin, which reduces its free concentration and leads to a delay in thrombin inactivation. Pefabloc SC, however, does not react with serum albumin, and exhibits a threefold higher capacity to inactivate thrombin under similar conditions.[4][5]
- Pefabloc SC can be used on living cells.
- Use Pefabloc SC to inactivate proteinase K, for example, during pulsed-field gel electrophoresis (PFGE).With this technique, isolating the genomic DNA requires proteinase K to degrade cellular components, and this highly resilient protease is difficult to inactivate. Pefabloc SC inhibits proteinase K, and protects the stability of restriction enzymes used for further DNA analysis.
Biochem/physiol Actions
Pefabloc SC belongs to the family of sulfonyl fluorides which irreversibly block serine proteases. Pefabloc SC was also described as potent serine threonine phosphatase inhibitor.
Features and Benefits
- Benefit from an easy-to-use inhibitor. Add water-soluble Pefabloc SC directly to aqueous buffers.
- Avoid hazardous compounds. Obtain non-toxic protease inhibition without risk to you, or those around you (see Figure 1).
- Ensure protection with improved stability. Achieve consistent protease inhibition even at pH levels above 7.0 and temperatures above +4°C (see Figure 2).
- Maximize inhibition. Be certain that your levels of active inhibitor are high enough by using a product that is reliably soluble and stable.
Preparation Note
Working concentration: 0.1 to 1 mg/ml (0.4 to 4 mM)
Working solution: Solvent is recommended in aqueous buffers or distilled water up to 100 mg/ml.
Storage conditions (working solution): -15 to -25 °C (stock solution)
The stability of Pefabloc SC in aqueous solution is affected both by pH and temperature. Concentrated stock solutions (e.g., 100 mM) prepared in dist. water are acidic and stable for 1 to 2 months at -15 to -25 °C, if stored in aliquots.
Note: Store Pefabloc SC under acidic conditions and add to biological samples shortly before use to minimize hydrolysis.
Working solution: Solvent is recommended in aqueous buffers or distilled water up to 100 mg/ml.
Storage conditions (working solution): -15 to -25 °C (stock solution)
The stability of Pefabloc SC in aqueous solution is affected both by pH and temperature. Concentrated stock solutions (e.g., 100 mM) prepared in dist. water are acidic and stable for 1 to 2 months at -15 to -25 °C, if stored in aliquots.
Note: Store Pefabloc SC under acidic conditions and add to biological samples shortly before use to minimize hydrolysis.
Soluble up to 100 mg/ml in aqueous buffers or water. Stable in solution for 1 to 2 months if stored in aliquots at -15 to -25 °C. Only slight hydrolysis occurs under weakly basic conditions (pH 8.0 to 9.0).
Analysis Note
Function tested; homogeneous in TLC
Other Notes
For life science research only. Not for use in diagnostic procedures.
Legal Information
Pefabloc is a registered trademark of Pentapharm
1 of 1
This Item | |||
|---|---|---|---|
| form powder | form powder or crystals | form crystalline | form solid |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| solubility aqueous buffer: 100 mg/mL | solubility - | solubility soluble (Solubility and stability of the protease inhibitor remains unchanged.) | solubility 10 g/L |
| mol wt Mr 239.5 | mol wt - | mol wt 239.5 | mol wt - |
| mp 175-185 °C | mp - | mp 175-185 °C | mp 175-177 °C |
| packaging pkg of 1 g (11429876001), pkg of 500 mg (11585916001), pkg of 100 mg (11429868001) | packaging - | packaging pkg of 5 mL (100 mg) | packaging - |
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Skin Corr. 1B
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Storage Class
8A - Combustible corrosive hazardous materials
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Roxanne C S van Adrichem et al.
Endocrine connections, 5(4), 143-151 (2016-05-25)
To date, the value of fasting plasma acylated ghrelin (AG) and unacylated ghrelin (UAG) as potential novel biomarkers in patients with neuroendocrine tumors (NETs) is unknown. The aims of this study are to (i) compare fasting AG and UAG levels
Jae Wook Hyeon et al.
Scientific reports, 5, 14944-14944 (2015-10-10)
Prion diseases are associated with the conformational conversion of the physiological form of cellular prion protein (PrP(C)) to the pathogenic form, PrP(Sc). Compounds that inhibit this process by blocking conversion to the PrP(Sc) could provide useful anti-prion therapies. However, no
Theresa J Barberi et al.
PloS one, 7(1), e29808-e29808 (2012-01-13)
Pin1 has previously been described to regulate cells that participate in both innate and adaptive immunity. Thus far, however, no role for Pin1 has been described in modulating conventional dendritic cells, innate antigen presenting cells that potently activate naïve T
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 11429876001 | 04061838250865 |
| 11429868001 | 04061838701947 |
| 11585916001 | 04061838703897 |